Search by Drug Name or NDC

    NDC 70436-0203-82 Dobutamine 250 mg/20mL Details

    Dobutamine 250 mg/20mL

    Dobutamine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Slate Run Pharmaceuticals. The primary component is DOBUTAMINE HYDROCHLORIDE.

    Product Information

    NDC 70436-0203
    Product ID 70436-203_f5cd978c-4e1d-2447-e053-2a95a90add3f
    Associated GPIs
    GCN Sequence Number 064535
    GCN Sequence Number Description dobutamine HCl VIAL 250MG/20ML INTRAVEN
    HIC3 A1C
    HIC3 Description INOTROPIC DRUGS
    GCN 14575
    HICL Sequence Number 000040
    HICL Sequence Number Description DOBUTAMINE HCL
    Brand/Generic Generic
    Proprietary Name Dobutamine
    Proprietary Name Suffix n/a
    Non-Proprietary Name dobutamine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 250
    Active Ingredient Units mg/20mL
    Substance Name DOBUTAMINE HYDROCHLORIDE
    Labeler Name Slate Run Pharmaceuticals
    Pharmaceutical Class Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216131
    Listing Certified Through 2024-12-31

    Package

    NDC 70436-0203-82 (70436020382)

    NDC Package Code 70436-203-82
    Billing NDC 70436020382
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (70436-203-82) / 20 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2023-04-03
    NDC Exclude Flag N
    Pricing Information N/A